CCR6 activation links innate immune responses to mucosa-associated lymphoid tissue lymphoma development

@article{Korona2022CCR6AL,
  title={CCR6 activation links innate immune responses to mucosa-associated lymphoid tissue lymphoma development},
  author={Boguslawa Korona and Dagmara Korona and Wanfeng Zhao and Andrew C. Wotherspoon and Ming-Qing Du},
  journal={Haematologica},
  year={2022},
  volume={107},
  pages={1384 - 1396},
  url={https://api.semanticscholar.org/CorpusID:246701314}
}
These findings suggest that CCR6 signaling is most likely active in MALT lymphoma, independent of its mutation status, and explain why the emergence of malignant B cells and their clonal expansion in Malt lymphoma are typically around LEL, linking the innate immune responses to lymphoma genesis.
[PDF] Semantic Reader

Figures from this paper

5 Citations

Clinical relevance of molecular aspects in extranodal marginal zone lymphoma: a critical appraisal

None of other genetic changes seen in MALT lymphoma to date has discernible value in routine clinical applications, but recent data suggest that changes in TNFAIP3(A20), KMTD2 and CARD11 might be associated with response to Bruton kinase inhibitors.

CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting.

Progress of CCL20-CCR6 in the airways: a promising new therapeutic target

A comprehensive understanding of the CCL20-CCR6 axis and its implications for respiratory health and disease is provided to propel research endeavors in this domain and furnish valuable insights for the development of future therapeutic strategies.

CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases

The potential as a therapeutic target of the C CR6 receptor in numerous diseases and the importance of the development of antibodies against CCR6 that could be a promising alternative to small molecules in the treatment of CCR 6/CCL20 axis-related pathologies are highlighted.

Chemokine Expression in Well‐Differentiated Liposarcoma May Be Involved in the Tumorigenesis of Lymphoplasmacytic Lymphoma: A Case Study

Liposarcoma and lymphoma are very rare tumors, and their combination is extremely rare. Moreover, there have been no reports of liposarcoma and lymphoma occurring in the same region.

46 References

Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites

These findings unravel novel insights into the molecular mechanisms of MALT lymphoma and provide further evidence for potential oncogenic co-operation between receptor signaling and genetic changes.

MALT lymphoma: A paradigm of NF-κB dysregulation.

CCR6 is a functional chemokine receptor that serves to identify select B-cell non-Hodgkin's lymphomas.

CCR6 is a useful new marker identifying a subset of B-cell non-Hodgkin's lymphomas and likely contributes to the localization of select extranodal lymphomas at mucosal sites.

Distinct signatures of B‐cell homeostatic and activation‐dependent chemokine receptors in the development and progression of extragastric MALT lymphomas

The results support a model of stepwise progression of extragastric MALT lymphoma from a non‐neoplastic event to Sjögren syndrome, to Malt lymphoma, and finally to overt eDLBCL, guided by differentially expressed B‐cell homeostatic and activation‐dependent chemokine receptors and their ligands.

GPR34 activation potentially bridges lymphoepithelial lesion to genesis of salivary gland MALT lymphoma.

These findings advocate a model of paracrine stimulation of malignant B-cells via GPR34, in which PLA is released by LELs, and hydrolyzes the phosphatidylserine exposed on apoptotic cells, generating lysophosphatidolserine, the ligand for G PR34.

B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis

It is suggested that B-cell receptor-derived signals cooperate with T-helper cell signals in driving the progression of MALT lymphoma, providing an explanation for the unique antigen dependence of this B- cell malignancy.

Thyroid MALT lymphoma: self-harm to gain potential T-cell help

CD274/TNFRSF14 inactivation in thyroid MALT lymphoma B-cells may deregulate their interaction with T-cells, promoting co-stimulations and impairing peripheral tolerance.

Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4‐34 usage in mucosa‐associated lymphoid tissue lymphoma

A significant association is shown between biased usage of autoreactive IGHV and somatic mutation of NF‐κB regulators in MALT lymphoma, arguing for their cooperation in sustaining chronic B‐cell receptor signalling and driving oncogenesis in lymphoma development.

Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation.

It is suggested that CD40 signaling in combination with Th2 cytokines are essential for the development and progression of low-grade MALT-type B cell lymphomas and may contribute to lymphoma pathogenesis.

Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination.

The hypothesis that the API2-MALT1 fusion protein can contribute to MALT lymphoma formation via increased NF-kappaB activation is supported.